How patients are helping Scotland say yes to more medicines
This article was originally published in Scrip
Executive Summary
The Scottish Medicines Consortium, Scotland's health technology assessment agency for new medicines, is saying yes to more and more drugs, and greater involvement of patients in the decision making process seems to be the reason why. The SMC's chief pharmacist Anne Lee spoke to Scrip about how patient views are affecting decisions, and the progress of the SMC's new Patient and Clinician Engagement (PACE) process, aimed at improving access to orphan and end-of-life treatments.
You may also be interested in...
UK: Commercial Framework Sheds Light On Working With NHS And NICE
The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.
Time Is Ripe For Global Action On Orphan Biosimilars
European industry association wants global convergence on development requirements, though the European Medicines Agency says that this would prove challenging.
Time Is Ripe For Global Action On Orphan Biosimilars
European industry association wants global convergence on development requirements, though the European Medicines Agency says that this would prove challenging.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: